Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study-Reference-Cited by-同舟云学术

Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study

Published:2019-09-23 Issue:2 Volume:61 Page:387-396
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Bhatnagar Bhavana¹²,Zhao Qiuhong¹²,Mims Alice S.¹²,Vasu Sumithira¹²,Behbehani Gregory K.¹²,Larkin Karilyn¹²,Blachly James S.¹²,Blum William³,Klisovic Rebecca B.³,Ruppert Amy S.¹²,Orwick Shelley²,Oakes Christopher¹,Ranganathan Parvathi¹²,Byrd John C.¹²,Walker Alison R.¹²,Garzon Ramiro¹²

Affiliation:

1. Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;

2. The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;

3. Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2019.1665664

Reference23 articles.

1. Acute Myeloid Leukemia